| Name | Title | Contact Details |
|---|
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure`s portfolio of products is sold globally to clinical laboratories, hospitals, physician`s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers.
Exo (pronounced “Echo”) is pioneering a high-performance handheld ultrasound platform and AI for imaging and therapeutic applications.
Saratoga Ventures LP is a Saratoga, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We focus on improving the lives of our patients with collaborative care, breakthrough research and by training tomorrow`s physicians. We are University of Minnesota Physicians, the multi-specialty group practice for the University of Minnesota Medical School faculty. As clinicians, we practice in primary care and over 100 specialty and subspecialty areas. As educators, we apply our state-of-the-art knowledge to teach and mentor future physicians. As researchers, we address critical medical problems, then translate our research findings into novel therapies to benefit patients. Our physicians practice academic medicine in an environment of inquiry and education. They work closely with other specialists across disciplines so that our patients receive comprehensive, well-coordinated care tied directly to innovations developed by our research. At UMPhysicians, every employee and physician has a role to play in fostering a culture of integrity and demonstrating our values of Service, Innovation and Respect.
The world`s leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its mission is to improve lives by improving sight. To support this mission, Essilor allocates more than €200 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Its flagship brands are Varilux®, Crizal®, Transitions®, Eyezen™, Xperio®, Foster Grant®, Bolon™ and Costa®. It also develops and markets equipment, instruments and services for eyecare professionals. Essilor reported consolidated revenue of more than €7.1 billion in 2016 and employs 64,000 people worldwide. It markets its products in more than 100 countries and has 33 plants, 490 prescription laboratories and edging facilities, as well as five research and development centers around the world.